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ABSTRACT 
 
Introduction 
The Joint United Nations Programme on HIV/AIDS (UNAIDS) has set a target to end the 
Acquired Immuno-Deficiency Syndrome (AIDS) epidemic by 2030, following their proposed 
90-90-90 goals. In line with this, the HIV Care Continuum (HCC) was implemented as the 
standard of care by the South African National Department of Health to be practiced in all 
government facilities with HIV positive patients. A conceptual framework for Implementation 
Fidelity (IF) was used to determine the extent of fidelity to the HCC in rural Mpumalanga 
Province, northeast South Africa.  
Methods 
A convergent parallel mixed-method approach was used to collect information from two 
primary healthcare facilities (PHC). Quantitative data were collected from 200 patient record 
files through an IF checklist toolkit (based on the 2015 HIV treatment guidelines (HTGs)); and 
qualitative data were collected through in-depth interviews with eight healthcare workers 
(HCWs) attending to HIV positive patients at these facilities. Interviews were designed in line 
with the IF framework to explore factors affecting fidelity to the HCC. A fidelity score was 
generated by tallying all the ‘yes’ responses to the IF checklist toolkit, and a final fidelity score 
was ranked as high or low fidelity, based on the fidelity mean score.  We used logistic 
regression models to identify predictors associated with the outcome of treatment adherence. 
Quantitative analyses were done using STATA 14. MAXQDA 12 was used to analyse the 
HCWs’ interviews. 
Results  
Females comprised 72.0% of the study sample and approximately 2/3 of the participants had a 
CD4 count of 350 and below (CD4≤350) upon HIV diagnosis. The average overall fidelity 
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score was 32 out of 37, with 10% of the participants being defaulters. Females were more likely 
to be retained in care compared to males (OR 0.47, 95% CI 0.22-1.03, p=0.06) as were older 
patients. For every age increase of 10 years, participants were more likely to be retained in care 
(OR 0.71, 95% CI 0.51-0.99, p=0.045). Those not due to start ART according to the 2015 
HTGs (CD4>500) were also less likely to be retained in care, though this was not statistically 
significant (OR 1.47, CI 0.52-4.17, p=0.460). Gender and age interaction was not statistically 
significant (OR 0.73, 95% CI 0.39-1.35, p=0.315). 
Findings from the interviews revealed that guidelines were being followed; that is, patients 
were counselled and blood specimens drawn according to the guidelines. HCWs stated that 
they had difficulties in retaining patients in care. They further reported that although following 
the guidelines is a time consuming task, they do follow them because their priority is patients’ 
health and wellbeing. HCWs continue to welcome referral systems to hospitals, as this aided 
in treating patients that could not be treated at their healthcare facilities, but stigma continues 
to be a challenge and contributes to the difficulties in retaining patients in care. 
 
Discussion 
Although a positive attitude and a willingness to follow the guidelines was reported by the 
HCWs, they still struggled to ensure patients’ adherence to care and to trace patients who 
defaulted. Stigma continues to contribute to retention failure. Socio-demographic factors and 
moderating factors contribute to the extent of retention in care. Factors contributing to HIV 
retention failure should be addressed to ensure that fidelity to the HCC is maintained to 
decrease challenges in executing the new Universal test and treat (UTT) guidelines currently 
being practiced across government healthcare facilities in South Africa. 
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CHAPTER 1 
INTRODUCTION  
 
 
In this chapter the impact of Antiretroviral therapy (ART) in treating the human 
immunodeficiency virus (HIV) is reviewed. The Health Care Continuum (HCC) is defined and 
the role of Implementation Fidelity (IF) is explained. A conceptual framework is integrated in 
reviewing published literature on measuring IF. The chapter concludes with the aims and 
objectives of the study. 
 
1.1  Background 
 
HIV and AIDS continue to cause major health problems in the world, especially in developing 
countries like the Eastern and Southern African regions, which collectively contribute to more 
than half (51.8%) of the world’s HIV positive population. As of 2015, there were 36.7 million 
people living with HIV in the world, 19 million of them from Eastern and Southern African 
regions (1). The current overall HIV prevalence in South Africa is 12.7%. More specifically, 
the prevalence among the adult population 15-49 years old is 18.9%, among women 15-49 
years old is 22.3%, and among the young population 15-24 years old is 5.6%  (2). 
ART has played a pivotal role in reducing deaths of HIV infected people. South Africa alone 
has supplied approximately 3.4 million people with antiretroviral (ARV) treatment and 
continues to supply more ARV treatment with new infections. As a result of ART, AIDS deaths 
in South Africa declined from 207 685 in 2010 to 110000 in 2016 (3). This supports the 
effectiveness and importance of ART. ART requires high and strict level of adherence, i.e. 
taking the correct dosage at the correct time and regularly attending clinic appointments.  
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In 2014, UNAIDS set new and ambitious targets to end the AIDS epidemic by 2030 – these 
are often referred to as the 90-90-90 targets. The goal is that by 2020, 90% of all people living 
with HIV will know their HIV status, 90% of all people with diagnosed HIV infection will 
receive sustained antiretroviral therapy and 90% of all people receiving ART will be virally 
suppressed (4). Together with these goals, South Africa has adopted and implemented the 
World Health Organization (WHO) HIV guidelines (Universal test and treat-UTT) of testing 
and treating upon diagnosis (irrespective of CD4 count) as of September 2016 (3). With these 
new guidelines there is a requirement for a strengthened healthcare system for testing, linking 
and retaining the infected people in care.  
The HCC is an HIV care delivery system that comprehensively incorporates biomedical and 
social services to cater for people infected and living with HIV at the different stages of the 
illness. This continuum of care is a succession of stages that are incorporated from the moment 
an individual is diagnosed with HIV through to treatment of their infection (5). 
The South African National Department of Health adopted the following HIV treatment 
guidelines to address the HIV epidemic in the country:  
1. HIV diagnosis: diagnosis of HIV infection through HIV testing. 
2. Linkage and access to care: Connecting individuals who are diagnosed with HIV, to 
an HIV healthcare provider/ healthcare facility, where treatment and support can be 
offered.  
(An individual is said to be successfully linked to care when they are connected to a 
healthcare facility within 3 months after diagnosis). 
3. Retention in care: ensuring that the linked individuals receive on-going clinical 
monitoring; since treatment is a lifelong process, HIV infected clients need to receive 
regular HIV medical care.  
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Continuous monitoring also ensures early detection of defaulters or ‘loss to follow up 
candidates’. Poor retention is defined as failure to retain linked and ART initiated patients 
in care for 12 months. Those who failed to attend a total of 4 clinic visits in 12 months will 
be classified as ‘not retained’ and those who attended at least 4 clinic visits in 12 months 
will be classified as ‘retained’(6). 
4. Antiretroviral therapy (ART): Ensuring that eligible HIV infected individuals are on 
treatment to prevent HIV from making more copies of itself.  
Poor ART initiation of linked patients is failure to initiate ART after 3 months of diagnosis. 
5. Viral suppression: The optimal goal for ART; lowering the amount of virus in infected 
individuals thus keeping them healthy and helping prolong their lives (7, 8). 
Due to the effectiveness of ART in sustaining the lives of infected individuals, HIV has become 
a chronic and manageable condition, which has already resulted in millions of years of lives 
being saved and infected people leading productive lives when maintained on treatment (9). In 
the South African context, HIV care has been decentralised from hospitals to primary 
healthcare facilities (PHC). Extensive training has been conducted for healthcare workers 
(HCWs) to increase coverage and reach of HIV care and to also increase staff capacity in under 
resourced communities (10). This decentralisation of healthcare facilities to treat HIV patients 
at the clinic level has eased access to care for patients within communities (11). Facilities are 
more readily within reach for patients to get tested, diagnosed and treated. 
Access to care soon after diagnosis would greatly improve survival (12). Therefore, HIV 
diagnosis has to be followed by appropriate treatment because without linkage to appropriate 
services, individuals living with HIV would not be initiated on ART and consequently retained 
in care and would not achieve viral suppression, which is necessary to live a longer and 
healthier life.  
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Given the positive understanding that increased treatment of HIV infected persons slows 
transmission of the virus, HIV treatment guidelines (HTGs) are used as a mechanism to 
facilitiate testing, linking and retaining patients in care, which is crucial for decreasing the 
epidemic (8, 13). To that end, HTGs have been distributed and mandated to be followed by 
healthcare facilities in South Africa when caring for HIV patients. 
 
1.1.1 Implementation Research 
 
Implementation research (IR) examines the scientific approach to carrying out an intervention 
conclusively. It looks into what factors affect implementation and what the processes and 
outcomes of implementing an intervention are, with the goal of ensuring that the intervention 
is sustainable in its setting. The overall goal of IR is to understand how interventions operate 
in the real world and how these can be constantly improved. In IR, context (psycho-
sociocultural and / or environmental) plays a pivotal role. All stakeholders associated with an 
intervention are also important in IR (14).  
Implementation outcomes are deliberate actions that are employed to bring about an expected 
and desirable end. They serve as indicators for the success of an intervention. Examples of 
these are: acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, 
coverage, and sustainability. IR uses these outcomes in order to assess the extent to which  an 
intervention was implemented (15).  
This study focuses on fidelity, the extent to which an intervention or programme is 
implemented in accordance with the protocols and procedures that were originally designed by 
the organisers of the intervention (16). Fidelity is the extent to which patients are provided the 
precise intervention that was intended to be delivered to them at the outset (17). It is also 
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referred to as delivering the instructions as intended (18). Other terms used to describe the 
concept of fidelity are adherence or integrity of a programme. Fidelity further informs patterns 
that are outliers from the original intended intervention (19).  In this study, fidelity will help 
determine if following the guidelines results in improved adherence to ART by patients. This 
will assist in assessing how far the HCC intervention will produce desired results in HIV 
patients. 
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1.2  Literature Review  
 
Our literature review was conducted through searching Pubmed, Science Direct and Google 
Scholar search engines. We searched for literature from medical journals such as British 
Medical Journal, South African Medical Journal, Journal of Infectious Diseases, BMC public, 
Implemenation Science and other similar medical journals, as well as the National Department 
of Health (South Africa) website. We searched for articles using key words such as HIV/AIDS, 
diagnosis, linkage, retention in care, adherence, treatment, ARVs, ART, implementation, 
fidelity. The focus of our study was measuring fidelity of the HIV Care Continuum; thus, our 
literature review addressed how fidelity is measured and how this will be used in our study to 
meaure fidelity. 
Numerous ways of measuring fidelity of an intervention have been shown in the literature:  five 
main components include adherence, quality of (care) delivery, participant responsiveness, 
facilitation strategies and intervention differentiation/complexity (20). Carroll et al. 2017 
elaborate on these components by formulating a conceptual framework for implementation 
fidelity. This framework proposed that within the components of measuring fidelity, some of 
the components can be classified as moderating factors that influence implementation fidelity. 
Their study proposed four moderating factors of implementation fidelity: participant 
responsiveness, complexity of an intervention, facilitation strategies, and quality of (care) 
delivery, and that these moderating factors influence a fifth component, namely adherence. 
They argue that these four components rather facilitate adherence and are not a measure of 
fidelity on their own (Figure 1). Our study adopted this conceptual framework. 
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Figure 1. Conceptual framework of implementation fidelity (adopted from Carroll et al. 
2007) 
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1.2.1 Adherence 
 
Adherence in implementation research is defined as the extent to which the components of an 
intervention are delivered as prescribed by the protocol, it is be the main measure of fidelity 
(21). Adherence is further subdivided into more specific elements: content, coverage and 
dosage.  
Content is the ingredients of the programme given to the recipient. In the context of 
the HCC intervention, content will include counselling the patient, testing the patient, educating 
and referring the patient, as per the HIV treatment guidelines.  
 Exposure / dosage is the amount of intervention delivered in relation to the amount 
prescribed by the protocol; this includes frequency and duration of the intervention, and 
whether the frequency and duration of the HCC is as prescribed by the guidelines or not. There 
are numerous ways of measuring dosage in adherence to interventions. A study by Elliott and 
Mihalic (2004) used interviews and surveys to determine exposure. Their study determined if 
interventions were implemented for as long and as often as were prescribed. Another study 
used logs to record the number of times an intervention was carried out (22).  These helped the 
researchers to assess the frequency of implementing their respective interventions as was 
prescribed by each intervention. 
 Coverage refers to all patients who are recorded to be successfully diagnosed, linked 
into care and are actually receiving the care (23). For example, a study by Reed JB, et al, 2009 
showed that 28.0% of HIV infected persons were delayed entry into care, i.e. three months 
after their initial diagnosis, implying a decrease in coverage of HIV infected individuals (24). 
There are many factors which have been reported to influence adherence to ART negatively, 
namely: stigma – patients become reluctant to freely visit clinics for treatment and care;  
relationship with HCW – lack of rapport between HCW and the patient can contributes to high 
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patient defaulter rate; financial constraints – lack of finances to travel to clinics results in 
patients defaulting and not being successfully retained in care;  side effects – patients find the 
side effects of some medication unbearable and as a result they stop treatment; migration –  
patients move to a different city and can no longer be traced or confirmed to be still in care or 
not (25-27); HCW attitude – when HCWs have a negative attitude towards their patients, this 
makes it difficult for patients to be open and share their challenges (28). 
1.2.2 Quality of Care Delivery 
 
The manner in or extent to which the content of an intervention is carried out include provider 
preparedness, respectfulness and confidence (29). Studies suggest that high IF can be achieved 
if staff members are appropriately selected and given adequate training, coaching and support, 
as these factors would enable them to deliver the intervention at a higher quality level (30). 
Continuous programme evaluation will also improve quality of intervention delivery, as 
referring back to an evaluation report can help identify gaps that transpired (30).  One study 
suggests that poor IF can be a result of poor staff training and uncommitted staff members (31). 
Another study noted that lack of leadership from managers, in playing a supportive role in the 
clinic, contributed to ineffective practices of caring for patients in the clinic (32). 
1.2.3 Participant Responsiveness 
 
Participant responsiveness is how well participants (HCWs) respond to an intervention, as well 
as their judgment about the relevance of the intervention (21). The manner in which participants 
react to or engage in an intervention, their level of interest as well as attitude towards the 
intervention, affects how an intervention is executed. Other factors such as the relationship 
between the HCW and recipient of the intervention, and willingness of the HCW to engage the 
recipient in the intervention, also contributes to how an intervention is carried out (33, 34). 
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Studies have shown however, that it is not only the implementer of the intervention who 
determines responsiveness to the intervention, but the recipient’s perspective should also be 
measured to determine whether the intervention was  received as intended (35). In a 2010 study 
by Kempf et al., participants were likely to return to their respective clinics if they were treated 
well by the clinic staff. Also, if HCWs were respectful, patients were more likely to honour 
their clinic appointments (36, 37). On the contrary, if patients felt they were disrespected (38), 
not empathised with (36), or the HCW didn’t care about them (37), they were less likely to 
honour their appointment. Patients appreciate respectful treatment by their HCWs which 
encourages them to keep clinic appointments (37). When patients are disheartened, it affects 
the level of fidelity in which the intervention is implemented. 
1.2.4 Facilitation Strategies  
 
These are measures employed to ensure that standardised interventions are implemented in a 
uniform manner (21). Studies have not conclusively shown that facilitation strategies can 
indeed ensure effectiveness of interventions (41); however, some studies have shown that the 
fidelity of interventions increases after facilitation strategies in the form of training and external 
support were made available. This supports the notion that when added strategies are 
incorporated in an intervention, better results can be achieved (22, 28, 42) and, increased 
fidelity can result (43).   
Furthermore, research has shown that moderating factors – quality of care delivery, 
participants’ responsiveness, complexity of an intervention and facilitation strategies – may 
positively or negatively affect the implementation process and its fidelity; that is, the effect of 
one moderating factor on fidelity may be influenced by another moderating factor thus reducing 
implementation fidelity (43). 
  
 13 
 
In order to have confidence in the effectiveness of the HTGs, the fidelity of the guidelines 
would  have to be measured and reported on, so that we will be able to attribute the success or 
lack thereof of the outcome to the intervention (in this case, the HCC). When an intervention 
is being implemented, it is important to know if it was implemented as was initially planned or 
not (39). This way, if the intervention outcome is futile, appropriate measures can be taken to 
focus on the element(s) which may have contributed to its failure. 
1.2.5 Complexity of an Intervention 
 
This is the extent to which an implementer of an intervention finds the contents of the 
intervention understandable enough to carry out with ease. Studies have shown that if 
interventions are comprehensive, they will be implemented with high fidelity, compared to 
interventions that are unclear  and ambiguous (40, 41). Additionally, Dusenbury et al. (2003) 
and Mihalic (2004) assert that, “interventions that are well structured and less complex, 
produce higher fidelity compared to those that are unstructured” (23, 29). Therefore, in the case 
of the HCC intervention, the extent of fidelity will be determined by how the HCWs 
experienced the intervention ─ whether  they found the intervention easy, vague or complex to 
carry out. 
The moderating factors described above illustrate how fidelity of interventions can be 
effectively measured.  These will be used in our study to measure the extent of fidelity to the 
HCC by the HCWs of healthcare facilities in the Bushbuckridge region. 
 
1.3   Problem Statement  
 
Evidence-based interventions have shown that the HCC can be implemented effectively when 
guidelines are followed, and that if not implemented well, poor outcomes and failure to link 
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and retain patients in care will prevail, ultimately resulting in poor viral load suppression.Even 
though HTGs are readily available in the National Department of Health database and hard 
copies accessible to South African health facilities, there is still poor HIV diagnosis, linkage to 
care and retention in care especially among the male population (42). HIV continues to be a 
problem despite the fiscal and human resources allocated by the Department of Health to tackle 
the epidemic (3). Other studies that measure fidelity in implementation have been conducted 
for various programmes (43); however, there is a gap in the literature for studies measuring 
fidelity in the HIV continuum of care. 
1.4   Justification 
In order to achieve the 90-90-90 goals, it is crucial for the HCC to be implemented with 
maximum fidelity. It is important to have an understanding of the extent to which the HCWs 
adhere to the HCC. Because HCWs make use of HTGs when attending to patients, 
understanding their experiences and perception of the guidelines is essential as it will give an 
indication of how feasible these guidelines are at the HCW-patient level interactions. Our study 
examined the extent of implementation fidelity of the HCC within two rural healthcare facilities 
in Mpumalanga Province.  Our study will assist in identifying gaps that exists in healthcare 
facilities when attending to HIV positive patients. It will also highlight determining factors 
affecting HCWs in executing the HTGs. Furthermore, the study provides an opportunity to 
identify the gaps that have to be addressed to stay aligned with the UNAIDS targets. This will 
aid in understanding fidelity from a PHC level and how this translates to the standard of HIV 
care in South Africa, since PHCs are where the majority of patients receive their HIV care. 
This study also adds to the existing literature on factors affecting implementation fidelity and 
how moderators of an intervention affect fidelity, to inform how these moderators can be 
effective and transferable in real life setting.  
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1.5   Research Question 
 
What is the extent of implementation fidelity of the health care continuum among healthcare 
workers at two healthcare facilities in rural Mpumalanga Province? 
1.6   Aim 
 
To assess the extent of implementation fidelity of the Health Care Continuum, and to explore 
how moderating factors influence implementation fidelity of this continuum of care in two 
healthcare facilities in rural Mpumalanga Province. 
1.7   Objectives 
 
1. To determine the extent of adherence to the Health Care Continuum by healthcare workers 
using patient record files from August 2015 to December 2016 in two healthcare facilities in 
Agincourt, rural Mpumalanga Province. 
2. To explore, through in-depth interviews with HCWs, how the moderating factors of 
implementation fidelity affect healthcare workers’ adherence to the Health Care Continuum in 
two healthcare facilities in Agincourt, rural Mpumalanga Province. 
This chapter has highlighted on the role that ARTs has played in South Africa to date and how 
the HCC continues to be met with challenges to execute. We reviewed the literature to see how 
we can best identify these challenges. We explored the conceptual framework of 
implementation fidelity to give direction on how we’ll go about answering our research 
question, and also on how to measure fidelity to the HCC. The next chapter will focus on the 
methodology used to address our objectives and to answer our research question.  
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CHAPTER 2 
METHODOLOGY 
 
This chapter presents the research design used, study setting and target population for the study, 
data collection tools and procedures, data management, study variables and analysis plan. 
2.1  Study Design 
 
A cross-sectional, convergent parallel mixed-method study approach was used (Figure 2). This 
was best suited for the type of research conducted, as the HCC is a multifaceted intervention. 
Using either quantitative or qualitative methods alone would not have provided all the required 
information (44), whereas combining both methods provided a more comprehensive analysis 
better able to answer the research question (45). Our approach involved secondary analysis of 
routinely collected data from patient record files at two primary care facilities in Agincourt, 
Mpumalanga Province, as well as in-depth interviews with HCWs at the same two facilities to 
further explore the factors contributing to implementation fidelity. 
 
 
 
 
 
Figure 2. The convergent parallel mixed-method design by Creswell at al. 2007 
2.2  Study Setting 
 
Qualitative Data 
collection and analysis 
 
Compare or 
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This study was conducted at two Primary Healthcare Clinics (PHCs) in the Agincourt area in 
the sub-district of Bushbuckridge in the Mpumalanga province of South Africa. The area is 
covered by a health and socio-demographic surveillance system (Agincourt HDSS) established 
in 1992 and run by the Medical Research Council/Wits University Rural Public Health and 
Health Transitions Research Unit (MRC/Wits Agincourt).   
2.3  Study Population 
 
All patients 18 years and older from two PHCs in the Bushbuckridge sub-district were sampled. 
The sampling was based on the daily operational functions and the organization of the PHCs, 
as well as the quality of their filing systems. For the purposes of answering objective one, the 
study reviewed 200 patient record files from patients 18 years and older; 100 from each 
healthcare facility. For objective two, eight HCWs who attend to HIV positive patients at the 
chosen PHCs were recruited, four HCWs per PHC. These HCWs were a mix of professional 
nurses and lay counsellors. 
2.4  Sampling  
 
STATA 14 was used to calculate the required sample size of patient record files to review at a 
95.0% confidence interval; assuming a 50.0% prevalence of fidelity and 80% power.  Based 
on these sample size and power calculations, a minimum of 200 patient record files were 
required. Simple random sampling was conducted and 250 files were selected for review (46). 
These files are kept in a specified HIV-file cabinet in each facility and are filed alphabetically 
per patients’ surnames. We randomly selected 20 files each day for a total of 22 days. We 
selected files at random from the filing cabinets, as well as files from out-patients who had 
completed their consultation with the HCWs at the facilities on the day of data collection. Each 
file in the health facility has a file number, which assisted in avoiding duplication of selecting 
  
 18 
 
files on alternative days of data collection. If the file met our inclusion criteria, data was 
collected from it; if criteria were not met, the file was returned to the facility’s filing cabinet 
but the file number noted to avoid selecting that file again in the future. The final counts of 
files selected for data collection were 100 patient record files per healthcare facility.   
Exclusion criteria: 
 Patient files of individuals 18 years of age and older whose record files were incomplete 
(missing pages) 
 Patient files of antenatal patients. 
For objective two, purposeful sampling (47) to recruit four eligible HCWs per healthcare 
facility was undertaken.  This was conducted through consultation with the nursing sister in-
charge of each facility to advice on which HCWs were directly involved in attending to HIV 
positive patients. 
2.5  Data Collection and Tools 
 
Quantitative and qualitative data were concurrently and independently collected. For the first 
objective, an electronic-based fidelity checklist toolkit (Appendix 1) was used to collect data 
from the record files of patients attending the healthcare facilities during the August 2015-
September 2016 period. Data collected prior to the implementation of UTT in September 2016, 
were reviewed retrospectively. The toolkit used was adapted from an already published fidelity 
implementation study (43). The fidelity checklist toolkit was formulated with statements 
derived from the HIV treatment guidelines algorithm, as stated in South Africa’s National 
Treatment Guidelines (8).  
The first section of the toolkit collected patient demographic data. The second section collected 
data pertaining to the patient’s adherence. Adherence is measured across the spectrum of the 
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three phases of the HCC intervention. The fidelity checklist toolkit was structured according 
to each step in the continuum of care; each step outlined the adherence variables. A ‘yes’ 
variable was allocated to the steps in the continuum which were followed, a ‘no’ variable was 
allocated to the steps which were not followed, and an ‘other’ variable was allocated to the 
steps which were partially followed. The ‘other’ responses were further re-coded as ‘yes’ or 
‘no’ depending on the extent of compliance to the HIV treatment guidelines. The ‘yes’ or ‘no’ 
answers were then tallied using STATA 14. Data was collected by the principal investigator 
(PI). 
The study principal investigator (PI) piloted the fidelity checklist toolkit with three patient 
record files to assess if the toolkit would gather all the needed information. Post piloting, the 
PI amended the toolkit by removing those questions which were not relevant or could not be 
answered by reviewing patient record files alone (Appendix 1). 
For the second objective, eight in-depth interviews were conducted by the PI with the selected 
HCWs (four per healthcare facility). Informed consent was obtained (Appendix 2) from the 
HCWs prior conducting the interviews. The interviews explored how moderating factors of 
HCC would influence adherence to the intervention and ultimately fidelity to the whole 
intervention.  Unstructured open-ended audiotaped interviews were conducted in English and 
transcribed by the PI; with the exception of one interview which had to be conducted in Sepedi 
(also by the PI), then translated to English and transcribed. An interview guide from a similar 
study which explored factors influencing implementation fidelity, was adopted and modified 
for this study (48). The interview guide was piloted with other HCWs prior to use and adjusted 
accordingly (Appendix 3). 
2.6  Study Variables  
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The study’s overall outcome variable is fidelity; overall fidelity score and fidelity scores for 
each phase of the HCC were computed. The scores were obtained by tallying the total ‘yes’ 
answers based on yes/no answers from the fidelity checklist toolkit. The scores were presented 
as continuous variables and then recoded into categorical variables (high and low fidelity).  
The mean score was used as the determining factor for low or high fidelity score, where scores 
below the mean were categorised as low fidelity and those above the mean as high fidelity. The 
categorised fidelity scores were computed for regression analysis. Out of the fidelity scores 
generated, regression analysis was conducted with the outcome of fidelity retention (the third 
phase) because retention was used as a proxy for adherence to ART. 
The predictor variables were all the other variables in the fidelity checklist toolkit. These 
variables were used to calculate overall fidelity scores as well as fidelity scores at each phase 
of the HCC. These variables were also used to test for associations. 
Coverage was measured to determine the proportion of patients in care as of August 2015, who 
were still in care at the time of data collection. 
Patient characteristics - including age, gender, marital status, occupation as well as HIV status 
(CD4 count at time of diagnosis) and indicators for measuring adherence (on-going adherence 
support, adherence noted, collected all prescriptions, side effects, stigma disclosure, caregiver 
support group, quarterly counselling and patient adherence>/=95%) -  were collected.  
The qualitative measure of fidelity was conducted via in-depth interviews through exploring 
the four moderators of fidelity: 1) quality of (care) delivery, 2) participant responsiveness, 3) 
facilitation strategies, and 4) complexity of an intervention. Coding of the interviews was done 
and themes derived from the codes using thematic analysis. The themes were then coded into 
the four moderating factors for further reporting and analysis. The in-depth interviews sought 
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to explore how the moderating factors impacted on the HCWs’ ability to adhere to the HCC. 
The interviews covered an array of issues from the different stages of the HCC, including 
factors hindering or facilitating HCWs daily activities, what HCWs perceive as the main 
benefits of the HCC, and how HCWs document the work they do on a daily basis. 
2.7  Data Management 
 
Data coding, data entry, verification and cleaning was conducted by the PI. Data was entered 
into an Access database and cross-checked by exporting it into an Excel spreadsheet to check 
for completeness and consistency through filtering each variable to check for any missing 
values. The Access database is safely stored under password-protected archives in the 
MRC/Wits-Agincourt Research Unit’s server. The head of the Data Section at the Research 
Unit, as well as the PI’s study supervisors, have access to the data. 
The PI transcribed the digitally-recorded interviews verbatim, and double-checked the 
transcripts for accuracy by reviewing them multiple times against the recordings.  
 Reliability: Capturing of the quantitative data into the Access database, data export to Excel, 
and checking for missing variables was conducted by the PI. The PI designed the Access 
database used for data-capture, and set validation rules for each variable to prevent capturing 
of incorrect data.  Coding and recoding of the qualitative in-depth interviews was conducted 
by the PI with two other qualitative researchers to ensure trustworthiness of the codes produced. 
Validity: To ensure validity, similar checklist toolkits for measuring fidelity and interview 
guides from other published work were adapted, modified and adjusted for the purposes of this 
study. 
2.8  Data Analysis 
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Quantitative and qualitative data were also concurrently and independently analysed. STATA 
14 was used to analyse the quantitative data. Descriptive analysis of summary statistics, and 
frequency tables of the demographic characteristics were reported in order to describe the 
characteristics of the participants. Continuous variables were summarised with sample size (n), 
mean, standard deviation (SD) and range (maximum and minimum). Categorical variables 
were computed into frequency and percentage for each category observed. 
Content and Dose variables were coded as ‘yes’ and ‘no’. These were summarised into 
frequency tables and calculated into percentages. Fidelity scores of the different phases of the 
HCC (i.e. Counselling; Testing and Diagnosing; Linkage to care and ART initiation; and 
Retention in Care) were tallied, calculated and reported as the mean (average scores), SD and 
range (maximum and minimum). From the fidelity score of retention, an adherence score was 
generated. 
A chi-squared test or Fisher’s exact test was used to test for associations of the content and 
dose variables. Since retention is a proxy of the ultimate goal of viral suppression in the HCC, 
further analysis was conducted with the fidelity retention score as the final outcome (Table 1).  
A summary of the retention fidelity score was determined; minimum, mean and maximum 
values were produced; all values above the mean were classified as high fidelity score; all 
values below the mean were classified as low fidelity score; and regression analysis was 
conducted. Univariable analysis was computed for occupation, marital status and CD4 count 
status at time of diagnosis.  Some of our variables could not be analysed because they generated 
empty cells when computed. The reason for the empty cells was because answers from the 
checklist were either all yes or all no; these types of outputs could not be fitted into the 
univariable regression model and ultimately the ordinal regression model used for analysis. 
  
 23 
 
When testing for normality of our outcome variable, the results presented a histogram graph 
skewed to the left, warranting the use of an ordinal regression model (see Figure 3 in Results 
section below). 
Further univariable analyses were conducted to select variables to be included in the 
multivariable analysis. Variables which were found to be significantly associated with the 
adherence score were retained in the final multivariable logistic regression model.  
Coverage looked at the proportion of patients who were diagnosed with HIV and linked to 
care, the proportion of patients linked to care and initiated on ART, and the proportion of ART 
initiated patients retained in care. Proportionality test was used to analyse and report coverage 
data, where the numerator was the number of patients retained in care, and the denominator the 
number of patients initiated on ART. 
The in-depth interviews were transcribed verbatim, the raw data transcribed was then reviewed, 
synthesised and codes identified by hand using a thematic analysis. 
An initial (top-down) broad coding framework using a thematic approach was developed based 
on the study research questions (49) and Carroll et al. 2017’s implementation framework (21).  
From the broad codes, we proceeded to apply fine (specific) codes to all transcripts, initially 
manually and then using MAXQDA 12. (50) The fine codes were used to derive themes which 
were coded into Carroll et al. 2017’s moderating factors framework. An analytical summary of 
each theme using illustrative quotes to support key emerging conclusions was developed. 
The interview guide and the final themes reported are based on these moderating factors: 
participant responsiveness, facilitation strategies, complexity of an intervention and quality of 
deliverance. Triangulation of the quantitative and qualitative results is presented in Table 1 
below. 
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Table 1. Summary of data collection and analysis 
 Quantitative Qualitative  
Data Collection Tools Fidelity Checklist Toolkit Interview guide 
Variables / Themes Content & Dose: Variables under content and 
dose derived from the guidelines were given 
statements ‘yes’ & ‘no’ codes. 
Coverage: the numerator is the number of 
patients retained in care, the denominator is the 
number of patients initiated on ART. 
Quality of care delivery, participant 
responsiveness, facilitation strategies, 
complexity of an intervention 
Data Analysis Content and Dose: Chi-squared, Fischer’s 
exact test, Univariable and Multi-variable 
analyses. 
Coverage: Proportion of coverage calculated. 
Codes derived from the interviews and 
categorised. Themes generated based on 
Carroll’s conceptual framework (21). 
 
2.9  Ethical Considerations 
 
Our study protocol was submitted to the Wits Human Research Ethics Committee (HREC) for 
review. Data collection began only after ethics clearance was obtained; our HREC certificate 
number is M1611105 (Appendix 3). Permission was also obtained from the Mpumalanga 
Province Research and Ethics Committee – our certificate number is PHREC REF 
MP_2017RP49_123 (Appendix 4); as well as from the study site (Appendix 5). Consent for 
reviewing the patient record files was previously obtained by the research Unit. An information 
sheet was provided to the study participants explaining the nature of the study and what was 
required of them for participation (Appendix 6). All participants consented prior to being 
interviewed, using approved consent forms (Appendix 7).  In addition to informed consent, 
permission from the participants to allow recording of the interviews was also obtained 
(Appendix 8). Participation was voluntary – participants (HCWs) were free to withdraw from 
the study if they wished to do so at any stage. Pseudo-names were used throughout the analysis 
and in this research report, in order to protect the identity of the participants. The signed consent 
forms are kept in locked filing cabinets at the Research Unit Voice recorded interviews are kept 
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in password-protected audio files in the Research Unit’s secured server, and will be kept for a 
period of two years and not made available for any member of the clinic facility. 
HCWs were told that there was no direct benefit in participating in the study, but that the 
information obtained could help them improve care and management of patients at the facility 
in the future.  
Patients’ records were kept confidential; no patient number or names were used for reporting 
purposes.  Patient record files were reviewed at the facilities, and never taken out of the 
facilities during the duration of the study. 
In our methodology, we identified the study design suitable for answering the research question 
at our study sites. We proceeded to statistically determine our sample, clearly stating the 
inclusion and exclusion criteria for our study. Data collection tools were developed to assist in 
collecting the appropriate data needed.  The data collected were analysed statistically and the 
results produced and interpreted in the next chapter.  
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CHAPTER 3 
RESULTS 
 
3.1  Introduction 
 
This chapter reports on the findings of our study. The quantitative section reports findings 
through tables and figures, with the major findings highlighted in the text. The qualitative 
section reports findings through quotes from the participants. The letters “PN” (professional 
nurse) and “LC” (lay counsellor) with unique numbers were assigned to each respective 
participant’s quote to distinguish the respondents while retaining confidentiality. 
 
3.2  Quantitative Analysis  
 
 A total of 200 patient record files of eligible patients were randomly selected for review and 
data collection, 100 record files per healthcare facility. 
Table 2 summarises descriptive statistics of the participants.  Females made up 72.0% of the 
sample population and more than half of the population (51.0%) was unemployed. The average 
age of the participants was 43.7, ranging from 22 to 87 years (SD 12.7), and the average number 
of years in HIV care was 3.5 years. Approximately two thirds of the participants had a CD4 
count of 350 and below upon HIV diagnosis. Based on the 2015 HTGs, 10% of the participants 
who were on ART were not supposed to be initiated in care because their CD4 count was 
greater than 500, and 3.5% of the study population were active TB patients at the time of HIV 
diagnosis. 
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Table 2: Descriptive statistics of socio-demographic characteristics of the participants 
 
 
 
 
  
 
Continuous Variables 
 
Variable No. of Observation Mean (SD) Min Max 
Age 200 43.70 (12.70) 22 87 
No. Years in Care* 200 3.54 (2.02) 0.34 11.74 
 
Categorical Variables 
 
Variable Frequency [N] (Percentage)[%] 
Gender  
Male 56  (28.0) 
Female 144 (72.0) 
Occupation  
Employed 46 (23.0) 
Unemployed 102 (51.0) 
Student 4 (2.0) 
Other 48 (24.0) 
Marital Status  
Single 111 (55.5) 
Married 70 (35.0) 
Divorced / Widowed 19 (9.5) 
HIV Category (CD4 Count at Time of 
Diagnosis) 
 
CD4 ≤ 350 135 (67.5) 
CD4 351-500 25 (12.5) 
CD4 > 500 20 (10.0) 
CD4 < 350 Active TB Disease 7 (3.5) 
CD4 < 200 WHO Stage 3 or 4 13 (6.5) 
Age Category  
20-30 24 (12.0) 
31-40 73 (36.5) 
41-50 49 (24.50)    
51-60 32 (16.0) 
61-70 15 (7.5) 
71-80 5 (2.5) 
81-90 2 (1.0) 
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HCWs in South African healthcare facilities adopted the HCC approach by following updated 
HTGs provided to them by the National Department of Health.  Patients in both healthcare 
facilities we visited were receiving HIV care under these guidelines. These guidelines were 
divided into 3 Phases: 1) HIV counselling and testing, 2) linkage to care and ART initiation, 
and 3) retention in care.  Our data shows that for Phase 1 of the care continuum, 7.0% of the 
participants tested for hepatitis B; 7.5% of these had CD4 < 350 and 0.5 % categorised under 
WHO stage 3 or 4 upon diagnosis of HIV.  None of the HCWs in the two healthcare facilities 
conducted additional regular counselling sessions after the patient was found to be HIV 
positive. All patient files scored 0.0% for the HCT conducted timeously variable (Table 3). 
Ninety-four percent of the participants diagnosed were linked to care within three months of 
HIV diagnosis; they were successfully linked to a healthcare facility and initiated on ART 
(Table 3). Furthermore, 68.7% of those successfully linked to care had a CD4 count of 350 or 
less upon diagnosis. Of the 6.0% not linked to care, 5.0% were female, 1.5% were married 
while 4.5% were single. Of those not eligible for ART initiation according to the 2015 HTGs, 
only 3 out of 20 were not successfully linked into care.   
For Phase 1 of the care continuum, the average fidelity score was 15 out of a total of 17 items 
checked (Table 4).  For Phase 2, all patients were reminded to honour their appointments 
through clinic cards, and they were continuously counselled about risky sexual behaviour, TB 
co-infection, other co-infections, and disclosing their HIV status to friends or family members. 
Only 35.4% of the female participants were tested for cervical cancer (Table 3). For Phase 2, 
the average fidelity score was 10 of 12 items checked (Table 4). For Phase 3, patient record 
files revealed different retention levels. Of the patient record files reviewed, 89.5% showed 
that the patients underwent monitored adherence support; that is, when patients visited the 
healthcare facility for their monthly check ups, they were monitored for their general well-
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being, TB and any adverse events from their medication. However, less than half (47.0%) of 
the patients collected all their prescriptions on the stipulated date, with a lower proportion of 
males (39.0%) compared to females (50%) collecting their prescriptions on time. In relation to 
marital status, 40.0% of participants who were single collected their prescriptions on time 
compared to 54.0% of the married participants. However, neither of these demographic 
characteristics was statistically significant, p=0.173 and p=0.119 respectively. Sixty seven 
percent of participants were linked to some sort of support group. Patient adherence level of 
>95.0% — patients having attended approximately 95.0% of their clinic visits according to 
their patient record files — was reported to be achieved by 80.5% of the participants (Table 3). 
The average fidelity score for Phase 3 was six out of a total of eight checked items (Table 4).  
 
Figure 3. Percentage of patients not retained in care 
  
10.50%
89.50%
Pie-chart depicting  defaulting patients
Defaulted patients Patients in care
  
 30 
 
Table 3: Fidelity scores for the HIV treatment guidelines descriptors 
Variables Yes No 
 N (%) N (%) 
Phase 1:  HIV Counseling and Testing 
Consent prior testing  200 (100.0) 0 (0.0) 
Positive 1st test retest 200 (100.0) 0 (0.0) 
Elisa test conducted for final results 200 (100.0) 0 (0.0) 
Post-test counseling conducted 200 (100.0) 0 (0.0) 
TB_Screening 200 (100.0) 0 (0.0) 
HIV_Education 200 (100.0) 0 (0.0) 
CD4 cell count tested 200 (100.0) 0 (0.0) 
Hepatitis 14 (7.0) 186 (93.0) 
Creatinine 200 (100.0) 0 (0.0) 
Clinical staging  200 (100.0) 0 (0.0) 
Viral load tested 200 (100.0) 0 (0.0) 
Continuous support and retesting 200 (100.0) 0 (0.0) 
HCT conducted timeously 0 (0.0) 200 (100.0) 
Provider decision making 200 (100.0) 0 (0.0) 
Provider treatment plan 200 (100.0) 0 (0.0) 
Provider care linkage 188 (94.0) 12 (6.0) 
Provider support group 196 (98.0) 4 (2.0) 
Phase 2: Linkage into Care and ART Initiation 
SMS technology (clinic card) 200 (100.0) 0 (0.0) 
TB screening at every visit 200 (100.0) 0 (0.0) 
Clinical staging  200 (100.0) 0 (0.0) 
Screening for STIs 200 (100.0) 0 (0.0) 
Counseling about partner 200 (100.0) 0 (0.0) 
Information risk reduction 200 (100.0) 0 (0.0) 
Support for disclosing 200 (100.0) 0 (0.0) 
Information on fertility/contraception 200 (100.0) 0 (0.0) 
Counseling on nutrition 200 (100.0) 0 (0.0) 
Screening comorbidity NCDS 200 (100.0) 0 (0.0) 
CD4 retesting 6monthly 200 (100.0) 0 (0.0) 
Cervical Cancer Screening for women* 51 (35.4) 93(64.6) 
Phase 3: Retention in Care  
Monitor ongoing adherence support  179 (89.5)  21 (10.5) 
Adherence noted  179 (89.5)  21 (10.5) 
Collected all Rxs   94 (47.0)  106 (53.0) 
Side effects   179 (89.5)  21 (10.5) 
Stigma disclosure  180 (90.0)  20 (10.0) 
Caregiver support group  134 (67.0)  66 (33.0) 
Quarterly counseling  179 (89.5)  21 (10.5) 
Patient adherence>/=95%  161 (80.5)  39 (19.5) 
               *only includes females; n= 144      
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Table 4 shows how the participants scored on each phase of care. Both facilities fared 
favourably in terms of the overall fidelity score, but on average facility 2 fared slightly better 
(32.97 score) than facility 1 (32.36 score). 
Table 4: Fidelity score for the different Phases of the Health Care Continuum 
 
Variable 
 
Facility 1 
 
Facility 2 
 
Overall Facility Score 
 Mean (SD) N (min-max) Mean (SD) N (min-max) Mean (SD) N (min- max) 
Person overall 
fidelity score 
32.36 (2.77) 100 (24-35) 32.97 (1.89) 100 (26-35) 32.67(2.39) 200 (24-35) 
Fidelity Score for 
Diagnosis 
15 (0.45) 100 (13-16) 14.98 (0.28) 100 (14-16) 14.99(0.37) 200 (13-16) 
Fidelity Score for 
Linkage 
10.2 (0.40) 100 (10-11) 10.3 (0.46) 100 (10-11) 10.25(0.47) 200 (11-12) 
Fidelity Score for 
Retention 
6.16 (2.63) 100 (0-8) 6.69 (1.84) 100 (0-8) 6.43 (2.28) 200 (0-8)  
 
The Fidelity Score for Diagnosis was calculated from 17 diagnosis predictor variables from 
Phase 1; the Fidelity Score for Linkage, from 12 linkage predictor variables from phase 2 and 
the Fidelity Score for Retention, from 8 retention predictor variables from phase 3 of the HCC 
(Table 4). The fidelity score for phase 3 was used to determine the level of adherence. The 
demographic variables (gender, occupation, marital status) were not found to be associated 
with fidelity retention score (Table 5).  
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Table 5: Associations between demographic variables and the retention in care outcome 
Variables Low Fidelity Score 
on Adherence: N (%) 
High Fidelity Score on 
Adherence: N (%) 
Chi2 & Fisher’s 
Exact p-value 
Gender    
Male 9 (16.1) 47 (83.9) 0.341 
Female 16 (11.1) 128 (88.9)  
Occupation    
Employed 4 (8.7) 42 (91.3) 0.108 
Student 2 (50.0) 2 (50.0)  
Unemployed 14 (13.7) 88  (86.3)  
Other 5 (10.4) 43 (89.6)  
Marital Status    
Married 57(10.0) 63 (90.0) 0.347 
Single 17 (15.3) 94 (84.7)  
Divorced / Widowed 1 (5.3) 18 (94.7)  
HIV Category (CD4 Count at Time of Diagnosis) 
CD4 ≤ 350 19 (14.1) 116 (85.9) 0.599 
CD4 351-500 2 (8.0) 23 (92.0)  
CD4>500 3 (15.0) 17 (85.0)  
CD4<350 Active TB Disease 1 (14.3) 6 (85.7)  
CD4<200 WHO Stage 3 or 4 0 (0.00) 13 (100.0)  
 
Since the retention score variable showed a skewed distribution (Figure 3), a logistic regression 
rather than a linear regression was computed. 
 
Figure 4: Distribution of person retention score 
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Table 6 describes how univariable and multivariable analyses of demographic factors relate to 
retention score, through fitting logistic regression models. A fidelity score of 6 and below was 
categorised to be failure of retention in care and a score of 7 and above was categorised as 
successful retention in care. The important factors from our univariable and multivariable 
analyses were gender and age. Females were more likely to be retained in care compared to 
males (OR 0.47, 95% CI 0.22-1.03, p=0.06) as were older patients. For every age increase of 
10 years, participants were more likely to be retained in care (OR 0.71, 95% CI 0.51-0.99, 
p=0.045). Participants who were single were less likely to be retained in care compared to 
married participants in univariable analysis (OR 1.9 95% CI 0.96-3.75, p=0.064), but after 
adjusting the model into a multivariable analysis this was not statistically significant (OR 1.47, 
95% CI 0.69-3.19, p=0.319). Although not statistically significant, those not due to start ART 
according to the 2015 HTGs were less likely to be retained in care (OR 1.01, 95% CI 0.31-
3.33, p=0.980). There was also no evidence of marital status having an impact on retention 
failure. 
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Table 6: Unadjusted and adjusted odds ratios of determinants associated with the 
retention phase of Health Care Continuum 
 
Variables Unadjusted/Univariable* p-value Adjusted /Multivariable* p-value 
Gender 
Male 1 (Reference)  1 (Reference)  
Female 0.65 (0.33-1.24) 0.194 0.47 (0.22-1.03) 0.06 
Occupation   
Employed 1 (Reference)  1 (Reference)  
Student -  -  
Unemployed 1.12 (0.51-2.5) 0.768 1.28 (0.55-2.99) 0.319 
Other 1.05 (0.42-2.63) 0.913 1.24 (0.45-3.45) 0.329 
Marital Status  
Married 1 (Reference)  1 (Reference)  
Single 1.9 (0.96-3.75) 0.064 1.47 (0.69-3.19) 0.319 
Divorced / Widowed 0.39 (0.82-1.90) 0.248 0.67 (1.3-3.44) 0.329 
HIV Category (CD4 Count Status at Time of Diagnosis) 
CD4</= 350 1 (Reference)  1 (Reference)  
CD4 351-500 0.55 (0.19-1.57) 0.268 0.55 (0.18-1.67) 0.291 
CD4>500 1.47 (0.56-3.88) 0.429 1.01 (0.31-3.33) 0.980 
CD4<350 Active TB Disease 0.37 (0.43-3.16) 0.363 0.37 (0.42-3.40) 0.386 
CD4<200 WHO Stage 3 or 4 0.40 (0.85-1.90) 0.250 0.45 (0.84-2.42) 0.354 
Age increase of 10 years 0.63 (0.48-0.85) 0.002 0.71 (0.51-0.99) 0.045 
* OR(95%CI)   
 
We generated interaction terms to further explore the relationship and associations between our 
study variables and retention score (Table 7). Our tested hypotheses are as follows: 1) being 
female and single is associated with higher fidelity retention score, 2) being female and eligible 
for ART according to the 2015 HTGs is associated with higher fidelity retention score, and 3) 
being female and older is associated with higher fidelity retention score. Our results show that 
single females are more likely to be retained in care but this was not statistically significant 
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(OR 0.72, 95% CI 0.16-3.14, p=0.957). Results also show that females who are not eligible for 
ART are less likely to be retained in care; this was also not statistically significant (OR 1.42, 
95% CI 0.57-35.43, p=0.832). Finally, although our results revealed statistical significance 
with the variables ‘gender’ and ‘increment in age’ in our multivariable analysis, interactions of 
these two factors did not show statistically significant results (OR 0.73, 95% CI 0.39-1.35, 
p=0.315). 
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Table 7: Adjusted odds ratios of the interactions between determinants associated with 
retention in care to the Health Care Continuum 
 
Variable Adjusted OR* p-value 
Gender # Marital Status   
Male # Divorced/Widowed -  
Females # Single 0.72 (0.16-3.14) 0.957 
Gender # Eligibility for ART  
Male 1 (Reference)  
Female # ART 1.42 (0.57-35.43) 0.832 
Gender # Age Increment   
Male 1 (Reference)  
Female # Age Increment 0.73 (0.39-1.35) 0.315 
* OR(95%CI)  
# Interactions symbol 
 
Defaulter Status 
Ten percent of the study population were defaulters (Figure 3). Sixteen percent of the male 
participants were defaulters whilst 7.0% were female. Nine percent of the defaulters were 
unemployed and 11.0% were employed. Fourteen percent of the defaulted participants were 
single whilst 4.0% were married, and 11.0% of the defaulters had CD4 count < 350 upon 
diagnosis of HIV whilst 5.0% had CD4 count >500 upon diagnosis. 
The overall proportion of patients retained in care in each healthcare facility at the time of data 
collection was 64.0% at Facility 1 and 78.0% Facility 2. These proportions were calculated as 
the number of patients retained in care divided by the number of patients initiated on ART in 
each healthcare facility. 
 
 
  
 37 
 
3.3  Qualitative analysis 
 
This section of the report summarizes the qualitative approach used to address the question 
‘What is the extent of implementation fidelity of the HIV care continuum among the healthcare 
workers at two healthcare facilities in rural Mpumalanga Province?’.  In-depth interviews with 
HCWs were done to explore how the moderating factors of implementation fidelity affect 
adherence of HCWs to the HCC under the themes: 1) quality of care delivery, 2) participant 
responsiveness, 3) facilitation strategies, and 4) complexity of an intervention, all derived from 
Carroll et al.’s conceptual framework for implementation. 
3.3.1 Descriptive analysis 
 
Eight HCWs who attend to HIV positive patients at Facilities 1 and 2 were interviewed. The 
HCWs comprised six professional nurses and two lay counsellors. At least two of the 
professional nurses was trained in ‘Nurse Initiated Management of Antiretroviral Treatment’ 
(NIMART) at each facility. All the professional nurses had prior experience in all disciplines 
of the nursing field, and all but one had prior hospital working experience. Working experience 
of the professional nurses ranged from 2 to 15 years. None of the lay counsellors had post-
secondary school education. 
3.3.2 Quality of Care Delivery 
 
This is the manner in or extent to which the content of the HTGs were carried out by the HCWs, 
including their preparedness, respectfulness and confidence when attending to patienst.  
All the HCWs reported that they conduct pre- and post- HIV counselling as well as test also 
confirmed conducting a confirmatory test after an initial HIV test has a positive result: 
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“you tell the patient about the testing kits…that this is ‘advance quality’ and this is ‘repeat test’…I’m 
going to test you with this one [‘advance quality’], this one [‘repeat test’] is to confirm (LC2).” 
“They [lay counsellors] counsel the patients and test them, though in their absence we (the nurses) do 
what they are doing (PN4)”   
“if you have given them a health talk in the morning… then you counsel them… again after 6 weeks [the 
patients] come and test (LC1).” 
Professional nurses mainly reinforce what lay counsellors discuss with HIV positive patients. 
Blood tests are drawn from patients and they are told to come back for their results, as outlined 
in the guidelines:  
“When we initiate the patient we collect blood for viral load at 6 months and from there at 12 months 
and from there on a yearly basis (PN4).”  
“We collect baseline, then you wait for the baseline…you come back and in 3 days’ time you contact the 
patient to say ‘can you come back so that we can check the results, to check whether you are fit to 
continue with the treatment?’(PN4).” 
The importance of patients accepting their HIV status and agreeing to start ART depends 
primarily on the HCW counselling patients appropriately, making sure that they understand 
their status and are aware of health changes happening to them and how to proceed when these 
changes occur.  HCWs also ensure that they supply the patients with a return date for treatment 
and re-evaluation: 
“…you let patient explain what, they were taught [during their initial counselling session] and you just 
add on to it…if you see this kind of side effects, it means there’s a problem so, you must address it (PN1).” 
“We phone the patient to come for initiation. So when they come for initiation, they go straight via the 
counsellor’s room again, then they will be taught or given the second lesson then they come this side, we 
reinforce the second lesson. Then we check the social readiness to start treatment then we initiate 
(PN3).”  
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Counselling sessions are conversational and include asking questions to ensure that patients 
understand what they were being counselled on. HCWs are also not confined to one job 
description – they test, counsel and draw blood from patients as required: 
“When I counsel, I ask. It’s a conversation (LC1).” 
“Thorough counselling of (about) taking medication when and how, and when a regimen has to be 
changed and under what circumstance, is what the HCWs do on a daily basis (PN5).”  
“I tell them everything…I give them time to also talk… then I fill in the rest of the information they missed 
(LC2).” 
Matters of concern regarding quality of healthcare were the non-availability of data capturers 
on weekends. This jeopardised the quality of care in that files could often not be retrieved and 
HCWs sometimes have to send patients home without their required medication:  
“Things that hinder us, like during the weekend we don’t have a data capture, we don’t have anybody to 
retrieve the files. You don’t really know whether the patient is on Bactrim because there’s no record, 
there’s nobody to retrieve the file. You can’t even get the file even if you try (PN4).”   
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3.3.3 Participant Responsiveness  
 
Participant Responsiveness is how well HCWs interacted with patients during their consults, 
as well as the HCWs’ judgment of the HTGs.  
HCWs interact with their patients and counsel them to ensure that they adhere to their 
medication. They start this process when patients are newly diagnosed and initiated on ART. 
HCWs explain to the patients the processes involved in taking their medication (when and how 
much), until the patient feels confident in taking their medication on their own.  
“I think that’s good, you know to sit down with your patient you know. If you need to do pill count 
monthly, it’s good, do it. So that the patient will understand, you know. You go through [everything] 
every time you… you’re with the patient. You remind them, ‘no you’re not supposed to… to miss pills. 
You know. Every day you must take your pills’ (PN1).” 
 “…so you must sit with the patient and give them again the adherence [re-enforce counselling] again 
the initiation they must have the adherence again [adhere to the HCC] (PN5).” 
Even though some HCWs give their patients all the support they can in terms of patients 
adhering to treatment, other HCWs become discouraged when patients stop adhering to 
medication because they feel they have done all they could to ensure patients were well 
educated regarding adherence:  
“Ah! patients are still the same…cannot change a person…yes even if they can change the guidelines 
but the person, you cannot change them (LC1).”  
On the other hand, other HCWs seem of the notion that encouragement should be given to 
patients who were adherent to their medication as a way of reinforcement.  
“You must praise your patient… they are encouraged you know (PN1).” 
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In general, HCWs seem keen to look after HIV positive patients and to ensure that these 
patients are retained in care, but they also had complaints of work overload having increased 
with the new guidelines of test and treat: 
“There’s a lot of work…. we are always tired” …. The work is too much but we are trying (PN2).”  
“So it’s a… it’s more workload at the Primary healthcare level (LC1).”  
“But at the very same time this hell lot of work has come with a lot of papers (PN4).” 
 “…me, I think they must be more staff (PN5).”  
Only one HCW did not seem to have complaints with the amendments of the guidelines:  
“Writing TDF 3TC Efavirenz…we just write FDC; one tablet daily times 28 days and then they go. It’s 
less now; I can say it’s less (PN6).” 
HCWs also presented contradictory perceptions on working with the guidelines. Some 
welcomed the guidelines and engaged with them to the best of their ability to ensure a patient 
is provided the appropriate care: 
 “Do the best, help the patient” (PN1).”  
“We really want to work and we are happy to see our people’s health becoming better (PN4).” 
 Others were disgruntled about the guidelines, because they see them as time-consuming and 
patients are not pleased with the waiting time: 
 “And the other thing it [new guidelines] even add some stress to us, you know when people are just 
screaming outside, you know, ‘yey you are just playing in the consulting room’, and they are saying all 
these things, you hear them inside here (consultation room) (PN4).” 
 However, overall, HCWs’ attitudes were more favourable toward their patients getting healthy 
than they were concerned about the workload: 
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 “Our patients mustn’t fall sick they must get treatment… me myself I’m happy when the viral is ‘LDL’, 
lower than the limit (PN5).” 
 “…because we want people to live long… (PN6).” 
HCWs were also very optimistic because prior to the new guidelines they attended to a lot of 
sickly patients; many patients were hospitalised or dying due to not being on ARVs whilst HIV 
positive: 
 “We are no more seeing patients who are now losing weight, we are no more seeing patients who are 
having those signs of HIV symptoms…The benefits, our patients are living long (PN5).” 
With the availability of treatment, patients can now live longer and healthier lives. HIV positive 
patients cannot be easily identified as they now look healthy and they live longer: 
 “For now everybody is the same you won’t identify…Main benefit, it’s even boosting economically 
because people are getting better they go to work (PN6).” 
HCWs took it upon themselves to initiate age-appropriate support groups amongst individuals 
who were treated for HIV, but these support groups were dissolved due to stigma arising 
against the patients within their communities. 
3.3.4 Facilitation Strategies 
 
These are measures employed to ensure that there is standardisation in implementing the HTGs 
if and when added assistance is needed by the HCWs. 
 HCWs also encounter instances where they are unable to treat patients effectively depending 
on the severity of the case.  These complicated patients are referred to the nearest hospital to 
be attended to by doctors: 
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 “But if there are… some results are high or very low that’s where we refer the patient to see the 
doctor…so if the patient, eh let’s take creatinine is very high, then we’ll refer the patient to the doctor 
(PN1).”  
“…we do refer them, like the one whose viral load is not controlled (PN2).” 
Referring patients assist the HCWs in effectively managing HIV patients and also ensures that 
guidelines are appropriately adhered to.  Primary HCWs’ scope of work does not allow them 
to attend to very ill patients, thus, referral ensures that these ill patients get the treatment they 
need at the secondary or tertiary level: 
 “…just like those patients who are really sick, you find that they have a very low CD4 count in a way 
that they have to be referred to the hospital (LC1).” 
At each healthcare facility, all information about patient treatment is recorded in each patient 
file.  Documentation of the information assists in ensuring that paper trail is maintained at all 
times and that whenever HCWs need to refer to any medication history about a patient, they 
can easily refer to the patient file: 
“We write everything we did then after that the capturer will take the files and capture them in the system, 
in our register (LC1).” 
Patient record files and registers assist HCWs in effectively tracking patients and following 
them up. They also help in ensuring that patients are given the correct treatment.  
The HCWs also find working with guidelines helpful in treating patients, because the 
guidelines explain all aspects of caring for an HIV positive patient:  
“…Because you always refer [to the guidelines] whatever you don’t understand, you always go to the 
index. So me I feel like it makes things more simple … maybe the part where, I can say the part where 
they (guidelines) eh, explain to you (PN1).” 
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“The guidelines help you to have a conversation with your patients…because it was difficult when you 
counsel, you were supposed to counsel lots of people, you were giving more information, but now it’s 
sort of a conservation (with the patient) (LC1).” 
HCWs also found the guidelines important as they aid in giving direction on what to do to 
effectively care for a patient: 
“I think it’s the most critical one because every day we deal with eh, maybe initiating patients, so that 
part for me is critical (PN1).”  
“The guideline now they help us... the guidelines are fine; the guidelines help you to have a conversation 
with your patients (LC1).” 
HCWs also appreciate the support they receive from fellow colleagues as well as from the 
district level and NGOs. Workshops they attend occasionally ensure that they are up to date 
with current treatment guidelines: 
“By having support, even to (from) our colleague, if there is something you don’t understand, you are 
going to one of the colleague (PN5).”  
 “When we have a workshop at the higher places, maybe we’re having the workshop at the district or 
sub-district….it makes it easier for the team to work (PN3).” 
 “I think there is support in a way that you may find that there’s a workshop maybe for Highly Active 
Antiretroviral Therapy (HAART) (PN2).” 
Assistance from other colleagues also means that one nurse is not overwhelmed with all the 
processes involved in caring for the patient. 
“Yah I think that they are helping us better because if you can look at it, you don’t do this thing (caring 
for patients) alone, there’s uhm the vital signs area, it has been done, the height it has been done for you 
(PN1).” 
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3.3.5 Complexity of an Intervention  
 
This is extent to which HCWs experienced challenges or executed their duties with ease when 
attending to patients in their facilities. 
There are many patients who default from their medication and from the HCC all together, 
making the intervention more complex and not as straight forward as expected: 
 “The other thing that demotivates us is the high defaulter rates of patients due to patient mobility. You 
are moving from one clinic to another, like now the patient initiates here, after 2 months you’ll receive 
a call from maybe Johannesburg (PN4).” 
 HCWs experience challenges in ensuring that patients understand and take ownership of their 
own health and ensure that they take their medication as prescribed: 
“So hence we have got increased rate of unsuppressed viral load, because people do not really 
understand (PN4).” 
The process of retaining patients in care goes beyond just ensuring that patients take their 
medication – HCWs need to constantly reinforce counselling and ensure patients collect their 
prescriptions on the due dates and take medication as prescribed:  
“…the patient needs serious re-adherence [reinforcement] again, maybe they are taking (their 
medication) but they are not sticking to the time (PN5).” 
Furthermore, HCWs not only cater for the clinical aspect of the patient, psychosocial 
interventions must also be considered by the HCWs as these are some of the reasons why 
patients default from their treatment. 
 “Sometimes they (the patient) have loss of appetite, sometimes they don’t have anything to eat at 
home…sometimes they don’t have source of income (PN6).” 
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HCWs also find it difficult to retain patients in care. When patients default, they have to ensure 
that they follow up on these patients, which they perceive as a task outside of their scope of 
work:  
“…but most of the time they [patients] use a phone, when we have some time we do call them and many 
a time the response to the call may be negative (PN5).”  
HCWs then make use of home-based carers to trace the defaulting patients and bring them back 
to be re-adhered back into treatment: 
“And then we…call, we also have uh, the home based carers(PN1).” 
“If we call the patient and they don’t, come, then the home based carers will go there…Ya, to check 
what’s going on, because sometimes you find that maybe the patient is sick or they are admitted [in 
hospital], but most of the time we’ll call and then the patient will come and then when they come, what 
we do we need to step up adherence (PN1).” 
“They [home based carers] go to the individual houses to go and check them (LC1).” 
Another factor contributing to the complexity of the HCC is the mobility of patients, migration 
due to work or due to stigma:  
 “They are not consistent, [a patient will say] I’m not there I’m at Johannesburg, now I’m taking a job 
(PN5).” 
 “Even on the forms we are not saying, concerning the HIV, just that we’re tracing the patients to come 
to the clinic, that’s where we’re going to tell the patient why are we tracing them (P7).” 
Despite the complexity of retaining defaulting patients, HCWs find the guidelines easy and 
straight forward to work with: 
“It’s not complex, its straight forward to be honest with you, because we do have guidelines to guide us, 
those with the challenges we refer… Simple and straight forward (PN1).”  
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Because of the perceived simplicity of the guidelines by some HCWs, their patients are 
compliant to the medication: 
“…but for now as they are taking 1,1,1, (one tablet each) … ah there’s no problem, they are complying 
now (PN6).”  
Another HCW believes that technology makes it easy to trace defaulters: 
 “So you don’t have a lot of people that are on’ loss to follow’ or patients whom you don’t know what 
happened to them, because even those that are far like Jo’burg [Johannesburg] or wherever, we call 
them through to come by the phone (PN5).”  
As it is evident from our report, different opinions were raised about the guidelines. Some 
HCWs feel they make the HCC simpler: 
 “for me I think…uhm the guidelines make things simple (PN1).”  
Some feel that the guidelines slow their working progress: 
 “…it will make you work slow but you will be doing the right thing because it’s there (PN3).” 
 Others feel the frequent changes to the guidelines make them difficult to follow and confusing:  
“The guidelines are changing, every time, now and then sometimes it confuses because you’ll still stick 
to that guideline meanwhile guidelines are changing every day (PN6).” 
This chapter summarised our results from the quantitative and qualitative data collected. Our 
analyses revealed a high HIV diagnoses and linkage to care rate, but a lower retention in care 
rate.  This low retention in care rate also includes patients who defaulted from care. HCWs 
were also interviewed to share their experiences on making use of the HTGs when attending to 
HIV+ patients. The following chapter will further elaborate on these experiences and the 
overall interpretation of our findings.  
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CHAPTER 4 
 
 DISCUSSION 
 
4.1  Introduction  
 
The aim of our study was to assess the extent of implementation fidelity of the HCC in two 
different healthcare facilities in Agincourt, rural Mpumalanga, and to explore how moderating 
factors influence implementation fidelity of this care continuum. Our study found that overall 
implementation fidelity of the HCC was high in both settings, and HCWs were prioritising 
patients’ health and wellbeing despite the challenges they were facing with retaining patients 
in care. 
4.2 Discussion 
 
The two healthcare facilities that participated in the study were selected based on their level of 
functioning: one was assessed better and one worse in terms of their operating systems. The 
two healthcare facilities have different filing systems and retrieve and store patient data in 
different ways that we hypothesised could influence the smooth operation of the facilities and 
ultimately the ease of carrying out the HCC. However, our results revealed that healthcare 
facility operating systems did not have a significant effect when determining implementation 
fidelity of the HCC carried out by the HCWs in each facility. 
Both healthcare facilities displayed a high implementation fidelity score, in that the HCWs 
were adherent to the HTGs given to them by the Department of Health. Higher implementation 
fidelity scores were observed in Phase 1 (HIV counselling and testing) and Phase 2 (linkage to 
care and ART initiation), while Phase 3 (retention in care) had a moderate to lower score. 
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The high fidelity score of Phase 1 implies that the HCWs followed this phase of care diligently; 
this was supported by findings from the interviews conducted with the HCWs. However, this 
high score likely reflects a bias because our study extracted data from patient record files – by 
virtue of a patient having a record file, that patient was already tested and diagnosed.  
The high score of Phase 2 also portrays the diligence of HCWs in following the HTGs. HCWs 
through the interviews emphasised counselling, empathy and HIV education. Findings from 
the checklist toolkit as well as from the interviews were in agreement regarding patient 
involvement in decision making during ART initiation processes; this ensured that patients 
were actively engaged in their care and that they knew when to return to the healthcare facility 
to be initiated into care.  
Similar studies which assessed efficacies (62) and challenges (63) of linking patients into care 
assert that involving patients in their own care and giving them specific appointments for ART 
initiation, further improved linkage to care. This current practice of patient involvement in care 
will prove to be very useful with the current UTT guidelines rolled out on 1st September 2016. 
This practice will ensure that more patients are effectively linked to care and initiated on ART 
as soon as they are diagnosed. 
The fidelity score for Phase 3 (retention in care) was moderately lower. HCWs reported facing 
challenges in retaining patients in care. They cited stigma and failure to trace defaulted patients 
as some of their major challenges. This finding is corroborated by other studies assessing 
adherence to HIV treatment and care. These studies found stigma, medication side effects and 
lack of support to be challenges in retaining patients in care and to achieving adherence (6, 51). 
In our study, peer support groups were noted by the HCWs as an intervention that assisted in 
reducing stigma amongst patients attending these groups; patients talked about the different 
challenges they are faced with as people living with HIV/AIDS and how they tackle these 
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challeges. Members of the support groups easily freely talked about their HIV status without 
feeling stigmatised by other peers in the group. Resources should be channelled to such 
interventions in order to reduce stigma and increase retention in HIV care. 
Findings from the fidelity checklist toolkit reveal that the HTGs were appropriately followed. 
HCW interviews also confirmed that quality of care was provided in attending to patients; the 
high fidelity scores for Phases 1 and 2 showed that the HCC processes were indeed conducted 
by the HCWs; that is, content and dose of Phase 1 and 2 of the continuum were executed 
effectively. 
HCWs displayed thorough knowledge of the HTGs as they were able to relay the information 
they share with patients during their consultations (content). The HCWs also showed 
knowledge of how often and how many times certain processes are administered to the patient 
according to the HTGs (dosage).  
HCWs, however, deviated from the guidelines when conducting timeous counselling sessions. 
Although they reported counselling patients timeously in the interviews, the fidelity checklist 
toolkit found contrary findings. The fidelity checklist toolkit showed a 0.0% score for ‘HIV 
Testing and Counselling (HCT) conducted timeously’. It transpired that the practice in these 
facilities is that once patients are tested positive and are taken to the NIMART nurses, they do 
not return back to the lay counsellors for further counselling, reaffirming the 0.0% HCT score. 
As evident in the interviews, this could be due to lack of time in attending to patients, as well 
as the perception that once a patient has been attended to and counselled by a professional 
nurse; there is no need to go back to the lay counsellors for further counselling during follow 
up consultation meetings. Our fidelity checklist toolkit further confirmed that Phase 3 
(retention in care) is where most challenges arise in the care continuum. Difficulties in retaining 
patients in care negatively affect monitoring of viral load and viral load suppression (6). 
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Our results show that the level of fidelity is not only determined by the interaction of the HCWs 
with the HTGs when attending to patients; patient factors also influence the level of adherence 
to the care continuum. In our study, patient socio-demographic factors are found to be 
contributing factors in determining whether patients were adhering to care or not. We looked 
at age, occupation, gender, marital status and HIV status /category at time of diagnosis, to 
determine if the demographic factors contributed to adherence to treatment. As in other studies, 
our study also found gender and age to be contributing factors of retention; that is, females and 
older patients were more likely to remain in care (52, 53). Unlike other studies, (54, 55) we did 
not find occupation and marital status statistically significant in retaining patients in care, 
possibly due to small sample size .   
There is a challenge in linking patients with CD4>500 into care, i.e those patients not eligible 
for ART prior to the new UTT guidelines. HCWs should take note of patients who do not 
appear ill, as they may pose a challenge to being initiated into care, despite improved linkage 
processes at the healthcare facilities (56, 57). 
In addition to assessing the demographic factors that contribute to the fidelity score, we 
employed Carroll et al.’s framework of implementation fidelity to determine how moderating 
factors of the framework affected the fidelity score on HCWs’ daily practices at the facilities. 
This is discussed below.  
4.2.1 Quality of Care Delivery 
 
Our findings indicate that HCWs have executed the HCC to acceptable quality, displaying 
knowledge of what was expected from them in caring for HIV patients. During our interviews 
with the HCWs, they appeared confident in responding to questions and in verbally outlining 
their daily practices, detailing how they attend to and treat patients. 
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Each facility has at least two NIMART trained nurses to ensure high quality implementation 
of the HCC. In order to ensure that expertise and skills are appropriately distributed, lay 
counsellors are appointed as the first line of contact; they counsel and test patients for HIV. 
The distribution of skills and expertise ensures that the NIMART nurses get to focus on the 
clinical aspects of the HIV positive patient while also reinforcing that patients receive the 
appropriate counselling from the lay counsellors at the first point of contact. 
4.2.2 Participant Responsiveness 
 
HCWs had different perceptions about the use of the guidelines to treat patients. Some HCWs 
complained of the impracticality of using the guidelines ─ the guidelines are not easy to 
navigate through ─ thus, they often have to rely on experience or on each other when attending 
to patients.  They also found the guidelines to be time consuming but prioritised patient health 
above everything.  Some found the guidelines to be confusing as they were amended quite 
often, while others welcomed the guidelines and did not have problems following them. 
Moreover, HCWs reported that having good rapport with patients contributes to patients 
honouring their appointments at the healthcare facilities. 
HCWs also reported that they encourage patients who are doing well and empathise with those 
who are not. They would also reprimand patients who are not adhering to their treatment. 
HCWs stated that it was through this HCW-patient relationship that they learned how to react 
to or help patients who struggle adhering to care.  Kristofco et al. (1998) and Chesney (2000) 
also found that a good relationship between HCW and patient influences interventions 
positively. 
Compassion and empathy encourages patients to stay in care. These findings are supported by 
Bogart et al. (2013) and Kempf et al. (2013) who reported that “if HCWs were respectful, 
patients found this an incentive to honour their clinic appointments”. One HCW relayed an 
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experience with a patient thanking her (HCW) for taking care of him (patient) when he was 
sick; this encouraged the patient to continue with care. 
4.2.3 Facilitation Strategies 
 
The HTG is a standardised tool disseminated across all facilities in South Africa according to 
their respective classification – whether they are a tertiary, secondary or a primary health 
facility (58) –  to ensure standardization of treatment in the HCC.  Roen et al. (2003) stated that 
standardisation of interventions helps ensure their effectiveness and fidelity. Findings from our 
study corroborates Roen’s findings in that through the standardisation of referral systems put 
in place across all healthcare facilities, patients are able to still receive the appropriate care and 
to remain in the continuum of care no matter how complicated their HIV status.  
The referral systems in place have helped ease the load at these two PHCs in dealing with 
‘complicated’ patients, and to ensure that patients receive the care they need at the hospital 
level, as NIMART nurses at the PHC level are not equipped to attend to all complications 
experienced by a patient.  As research has shown, referring patients ensures that they remain 
in care and do not default due to not seeing progress in their health status (59-61). 
We have learned from our study that healthcare facilities need to have well-managed filing 
systems in place, as this will aid HCWs in their practice. If patient record files are easily 
accessible to HCWs, and if these files are easy to navigate through, this will lessen the burden 
for HCWs as they will spend less time doing administrative work and more time examining 
the patient (60). 
HCWs have welcomed HTGs as tools to guide them in effectively managing patients and 
improving their work towards quality of care. HCWs also appreciated external aid from the 
district offices and NGOs. These are facilitation strategies that acted as a form of support in 
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assisting HCWs to render quality care. External support is seen as an enabler to carry out 
functions more efficiently (62, 63). 
4.2.4 Complexity of an Intervention  
 
Our results showed that the HCC was delivered with high quality of care ─ given the high 
fidelity scores for HCC’s phases 1 and 2 ─ and that facilitation strategies aid HCWs in 
executing daily practices. However, the interaction between HCW and patients is not as easy 
as the guidelines portray. The HCW counsel patients and instruct them on when and how to 
take their medication, but a patient will not necessarily follow a HCW’s instructions. Our study 
showed that although the majority of patients who were diagnosed with HIV were linked to 
care, it was also difficult to retain patients in care. Emphasis on patient education and 
empowerment should be reinforced because it is ultimately up to the patients if they will adhere 
to HCWs’ instructions or not.  Though other factors such as environmental and societal factors 
also play an important role, patient empowerment is vital (64, 65). 
Retention factors affect implementing the HCC with high fidelity.  The guidelines advise 
HCWs on what to do in order to ensure a patient is retained in care, but we found that fewer 
patients collected their refill prescriptions on time and fewer patients agreed to be included in 
some form of support group.  HCWs were also inconsistent in counselling patients on side 
effects during follow up appointments.  
Adding to the complexity of the HCC, HCWs need to counsel patients on psychosocial 
difficulties and on their clinical ailments due to medication side effects, as these factors may 
contribute to patients not adhering to treatment and eventually defaulting. Age-appropriate 
support groups were started by the HCWs to ensure patients received peer support in addition 
to clinical support, but these support groups were cancelled due to the stigma arising in the 
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community (66). HIV-related stigma continues to be a major challenge to be addressed in 
communities. 
At the two facilities observed, there was also consistent tracing of patients in order to maintain 
the continuum of care. HCWs often assumed the role of telephonically calling patients to trace 
them in the absence of home-based carers who visit the defaulted patients. HCWs found this 
additional work a challenge, as there was not enough time nor personnel to attend to matters 
outside of clinical ailments of patients. Despite the engagement of HCWs in tracing defaulting 
patients, the defaulter rate in our sample was 10%.  Thus, better and more innovative strategies 
could be employed, such as actively making use of mobile devices that send timely reminders, 
or initiating WhatsApp groups to engage patients with and to contact the defaulting patients. 
Guidelines could also be amended to include patients’ next of kin who is actively involved in 
patient care ─ this would provide HCWs with a contact person they can call to assist in sharing 
information regarding the whereabouts of the defaulting patient. Such interventions can assist 
in retaining patients in care (67). 
Furthermore, even though the guidelines are welcomed by HCWs, having to readjust to new 
guidelines also posed a challenge. Some HCWs feel that they have to unlearn what they are 
already practicing in order to adopt new guidelines, whilst also ensuring that patients adapt to 
the changes as well.  Some patients may be keen to adopt new guidelines, for example in 
moving from multiple to single regimen (reported by the HCWs during interviews). However, 
some patients may not welcome a change, for example those who do not feel sick may not see 
the need in being initiated on treatment as per the new ‘test and treat’ guidelines. 
4.2.5 Implementation Science Practice 
 
There were some adaptations to the guidelines that were being practiced at these two healthcare 
facilities, to ensure that patients received quality care even with limited resources. For example, 
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both facilities made use of a ‘patient green card’ instead of an SMS system to remind patients 
of their appointment. Knowing that patients stayed far from the healthcare facilities, HCWs 
also ordered double testing of patients’ bloods (testing for CD4 count and also instructing the 
lab to test for Hepatitis B if the CD4 count was below 100) – this ensured that patients did not 
have to travel numerous times to have their bloods tested and also ensured that they followed 
the guidelines. This contextualising of the intervention aligns well with implementation science 
theory. Adaptation is encouraged in implementation science, as long as it does not deviate from 
the core elements of an intervention. The HCWs made sure that even with limited recourses 
and under circumstances unique to their facilities, patients still receive the best possible care. 
  
4.3 LIMITATIONS  
 
Our study had some limitations. Selection of healthcare facilities for conducting the study was 
purposive rather than random, and the sample size was small.  There was no data in the patient 
record files which stated reasons for defaulting patients, this would have assisted in further 
exploring reasons behind the low fidelity score of retention, in addition to the retention factors 
already collected for this study. In addition, given high migration in the Bushbuckridge area, it 
is likely that some residents will be classified as loss to follow-up or as defaulters when they 
may have moved out of the area and are receiving care elsewhere.  
Patient record data entered by the HCWs (i.e. when a patient is due for CD4 count collection 
or when a patient is deemed a defaulter) was inconsistent in the files; this was overcome by 
standardising the fidelity checklist toolkit, collecting the raw data as it was and then applying 
the adaptation model after completion of the interviews with the HCWs. 
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Reporting biases by HCWs could not be conclusively avoided. The fidelity checklist toolkit 
was used to confirm as well as to note similarities and discrepancies between the findings. 
From our findings, even though the two healthcare facilities had different filing systems this 
did not result in different daily operating systems in the facilities. As a result, our findings were 
similar in the two facilities.  We found that HCWs were able to diagnose and link patients to 
care through active interaction with the patients, but stigma from the community was found to 
be a challenge. HCWs stated that stigma contributed to the low retention in care of patients. 
HCWs also appreciated the support from their district office as well as knowing that they can 
refer patients to tertiary hospitals whenever they were unable to treat the patient at their facility. 
From our study we were able to deduce when implementation practices employed, such as 
adaptation of some of the HTGs to fit the context. We were also able to identify gaps for better 
knowledge and improvement for future studies. 
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CHAPTER 5 
 
5.1 CONCLUSION  
 
This study aimed to determine the fidelity with which HCWs at two healthcare facilities in the 
Agincourt area of rural Mpumalanga Province implemented the HCC. Our study assessed the 
extent to which the HCWs adhered to the HTGs in order to retain patients in care. This was 
done by using a fidelity checklist toolkit derived from the 2015 HTGs. The toolkit was used to 
generate implementation fidelity scores for both facilities in each phase of the continuum of 
care, as well as an overall fidelity score. In addition, HCWs were interviewed about their 
interaction with and attitudes towards the treatment guidelines, using an implementation 
fidelity framework to develop the interview guide. 
 The study examined how the two healthcare facilities performed in achieving the 90-90-90 
goals. The overall fidelity score of the two healthcare facilities was generally high; however, 
when breaking down the score to assess the extent of fidelity in the phases of the care 
continuum, retention in care showed a lower fidelity score. Missed prescriptions, stigma, lack 
of support groups, and defaulting patients were some of the predictors measured in our 
checklist toolkit which contributed to the lower retention fidelity score. Although HCWs feel 
they have good support and delivered quality of care to their patients, they also reiterated 
having difficulty retaining patients and tracing defaulters. The quality of the HCW-patient 
relationship was noted by HCWs as a contributing factor to patients remaining in care. 
The role that patients play in the continuum of care is also critical to achieving maximum 
adherence, and socio-demographic factors such as age, gender, marital status and occupation, 
as well as HIV status (CD4 count status at time of diagnosis) should also be taken into account 
by contextualising care when attending to different socio-demographic groups. 
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Through assessing implementation fidelity, we were able to examine the role of 
implementation science. We were able to determine how we can adopt what is already known 
as an effective intervention (in this case the HCC) ─ tailor and contextualise it to similar 
facilities ─ to ensure that results are achieved while we still retain the core elements of the main 
intervention. This is of great importance as South Africa is now implementing the new UTT 
guidelines. Our study assisted in identifying some challenges that HCWs are faced with on a 
daily basis when working with the older guidelines. From our findings, enhanced staff capacity, 
user-friendly guidelines, better filing systems and better strategies of disseminating guidelines 
are needed to effectively implement UTT. 
Mobile health technology is currently being used by HCWs in some countries when attending 
to patients(68). Diagnosing, monitoring and prescribing for patients at a distance has now 
become possible. This can be a valuable stratergy to increase adherence among HIV+ patients. 
Stigma continues to be a problem in our study site community even with the adherence clubs 
being present. Making use of technology such as WhatsApp groups or other social media chats, 
can assit with creating non-contact adherence clubs, which can provide needed support to  
HIV+ individuals. What would normally be discussed at the physical adherence clubs or with 
HCWs could easily be discussed through these virtual media. Patients would continue to 
receive emotional support and encouragement without physical contact. These forms of support 
groups can be tailored for different seetings and populations. Stigma could be reduced, as it 
will not be known by community members when HIV infected people are meeting for their 
adherence clubs. 
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5.2 RECOMMENDATIONS     
 
Further implementation fidelity studies should include interviews with patients as well as with 
HCWs, and thorough review of patient record files. This will provide further insight from the 
patients’ and providers’ experience, and can help inform better decision-making with respect 
to tackling ART adherence. There is also a need for more qualitative research that explores 
HIV positive patients’ reasons for defaulting on ART and to understand what factors help 
patients adhere to ART.  This can inform policy on how to better serve defaulters and how to 
increase the number of virally suppressed patients. 
Quality improvement interventions on HCWs’ execution of the HCC should be conducted to 
strengthen support systems that aid HCWs to provide high quality care when attending to HIV 
patients. These could include: reviewing and developing more user-friendly guidelines for 
HCWs; permitting alterations to guidelines so that HCWs can adapt and improve their service; 
and required attendance of HCWs at regular in-service trainings. These interventions should 
be evaluated pre- and post-implementation to assess their impact on the HCC and on the 
provision of care that is relevant and appropriate to patients’ needs. 
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APPENDICES 
 
Appendix 1: Fidelity Checklist Toolkit 
 
A Study about Implementation Fidelity of HIV Care Continuum among 
Healthcare Workers in Agincourt Healthcare Facilities 
 
HIV Continuum of Care Fidelity Assessment Tool Kit 
Instructions 
o This tool has two sections; 1 addresses the demographic profile of the patient and 2 addresses 
adherence to fidelity using content and dose. 
o Scores are given for each statement that is present in the patient record. 
o Scores of 1 or 0 for yes and no answers respectively, are allocated. 
o There are no maybe or half-points answers. 
o Scores will be tallied separately under content and dose, per stage of care. 
 
1. Facility ID…………… 
 
2. Demographic profile 
 
1.Patient ID………  (for record purposes only and to aid traceability)            2.Age………………….. 
3.Gender: male / female/ transgender/unspecified/other……………………. 
4.Occupation: employed/ unemployed/ employer/student/ none/ other…………………. 
5.Level of education: (primary/ secondary/tertiary /none) 
6.Which category does this patient fall under at the commencement of diagnosis? 
a) Eligible to start ART 
• CD4 count ≤500 cells/μl irrespective of clinical stage 
• CD4 ≤350 cells/μl patient prioritised? (Yes/No) 
• Severe or advanced HIV disease (WHO clinical stage 3 or 4), started on ART regardless of  
CD4 count 
•  Active TB disease (including drug-resistant and EPTB) 
•  Pregnant and breastfeeding women who are HIV-positive 
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•  Known hepatitis B viral (HBV) co-infection 
Date when patient entered continuum of care…………… 
  
 67 
 
3. Measuring of adherence to the HIV treatment cascade using content and dose : 
 
Stage 1. HIV COUNSELLING AND TESTING 
HIV COUNSELLING AND TESTING  YES NO COMMENTS 
1.Was consent given prior testing    
First HIV test (If applicable):     
2. If test was negative, which of the following was done?    
 Post-test counselling     
 Repeat HIV test after 3 months     
 Educate on window period and HIV risk reduction    
 Repeat HCT for women on PMTCT program     
3. If test was positive, was second rapid test conducted?    
4. Was an Elisa test conducted to confirm the final results?    
5. If the final Elisa was positive, which of the following were conducted:    
 Post-test counselling     
 Same day TB screen (if not done already)    
 HIV education     
 CD4 cell count     
 HBsAg     
 Creatinine     
 Clinical staging     
 If a pregnant/breastfeeding, ART initiated on same day     
6. If the patient refused to test, what steps were followed:    
 Post- refusal counselling     
 Continuous offering of provider initiated counselling and testing with 
each visit  
   
7. HCT is repeated as per guidelines and timelines depending on the type 
of patient you are. Was HCT repeated timeously,(choose the applicable  
patient as per the medical record to check timeline of repeated HCT: 
   
 Pregnant and breast feeding women (to detect HIV sero-conversion)- 
every 3 months throughout pregnancy 
   
 Key population (every 6-12 months)    
 If exposed to HIV (after 6-12 weeks)    
 General population (every 6-12 months)    
8. At the time of HIV diagnosis, which of the following were communicated 
to the patient:  
   
 ART decision making with patient    
 Entire treatment plan explained and follow-up visit scheduled     
 Identified and addressed possible linkage to care     
 Advised  patients about  post-diagnosis support groups     
 Register pregnant women on MomConnect at the first antenatal care 
(ANC) visit  (if applicable) 
   
 Use of SMS technology to remind patients of appointments     
Each yes answer is given a score of 1 and each no answer is given a score of 
0, non-applicable answers are given a value of 99. Scores will be tallied on 
both content and dose and analysis will be conducted at this stage of the 
care continuum. Extent of fidelity of HCT implementation will be calculated. 
 
   
Additional comments 
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Stage 2.  LINKAGE TO CARE AND PRE ART INITIATION  
When patients have been diagnosed with HIV but are not yet eligible for ART initiation, they should 
be kept within the wellness programme where they are encouraged and given support to live a healthy 
lifestyle. Their CD4 cell count should be checked regularly, at least 6-monthly to assess eligibility for 
ART.  
LINKAGE TO CARE AND PRE ART INITIATION YES NO COMMENTS 
9. Which of the following were included in the pre ART initiation 
programme 
   
 TB symptom screening at every visit: test all who have a positive 
symptom screen; initiate INH prophylaxis if eligible and give TB 
treatment if tested positive for TB  
   
  Conduct clinical staging (at every visit )    
  Screening and management of sexually transmitted infections     
 Counselling on how to avoid HIV transmission to sexual partners and 
children  
   
 Information and counselling on risk-reduction and combination HIV 
prevention approaches  
   
  Support for disclosure and partner notification     
 Information and counselling related to fertility, including planning 
for conception or contraception, as needed  
   
 Counselling on nutrition and healthy lifestyle     
 Screening and management of co-morbidities and non-communicable 
diseases  
   
 Repeat CD4 testing and WHO clinical staging 6-monthly in adults 
and adolescents  
   
 An annual cervical cancer screening (pap smear) for all HIV-positive 
women  
   
Each yes answer is given a score of 1 and each no answer is given a score of 
0, non-applicable answers are given a value of 99. Scores will be tallied on 
both content and dose and analysis will be conducted at this stage of care 
continuum. Extent of fidelity of Linkage to care and pre ART initiation will be 
calculated. 
 
   
Additional comments 
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Stage 3. ART THERAPY AND RETENTION IN CARE 
Education on adherence to treatment starts at the beginning of the treatment cascade, when a patient is 
diagnosed as HIV-positive. Adherence includes taking treatment as prescribed, keeping to appointments 
for test results, referrals and further investigation. The patient’s motivation to continue engaging with 
care regardless of eligibility for ART is influenced by their experience with the healthcare system and 
the attitude of healthcare providers. 
Viral load suppression, clinical outcome and adherence should be explained to the patient. Adherence 
to treatment requires on-going assessment and monitoring, which should be part of each clinic. 
ART THERAPY AND RETENTION IN CARE YES NO COMMENTS 
10. Which of the following are conducted to ensure viral load suppression?    
 Monitor and offer on-going adherence support.     
 Adherence goal is >95% of doses taken. Patients with adherence <80% 
require more adherence support, was adherence noted 
   
 Are there any missed appointments for prescription collection     
 Counselling on side effects conducted     
 Adverse events, interim illness and issues around stigma and disclosure 
is continually addressed were these addressed  
   
 Was caregiver participation in a support group encouraged    
 Monthly counselling visits for the first 3 months     
 Quarterly counselling visits conducted after the 3 months     
11. Which other strategies were employed to increase adherence of all 
patients with <80% adherence at any visit and those with first VL>1000 
copies/ml (choose those which were conducted) 
   
 re-education of   patient, caregiver and their ‘buddy’ about the 
importance of adherence  
   
 Re-emphasising of  long-term benefits of adherence     
 Evaluate the support structures in place; whether they are appropriate, 
how they can be improved and explore other options  
   
 Encourage the patient to consider the use of pillboxes and/or a daily 
dosing diary  
   
 Encourage the patient to participate in a support group or create a link 
with a patient advocate  
   
 Looked at the psychological profile of the patient, to assess mental 
health issues/substance misuse  
   
 Increased home visits by therapeutic counsellors/patient advocates to 
daily or weekly at a minimum  
   
 Initiate spot pill counts to be conducted at home    
Each yes answer is given a score of 1 and each no answer is given a score of 
0, non-applicable answers are given a value of 99. Scores will be tallied on 
both content and dose and analysis will be conducted at this stage of care 
continuum. Extent of fidelity of ART therapy and retention in care will be 
calculated. 
 
   
Additional comments 
 
--------------------------------------------------------THE END------------------------------------------------------ 
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Appendix 2: Interview Guide  
 
 
Implementation Fidelity of HIV Care Continuum among Healthcare 
Workers in Agincourt Health Care Facilities 
 
Participant ID……………. 
Background and demographic information 
1. Could you tell me about your background in terms of education and work experience? 
2. Could you tell me about your current work? 
Quality in delivery 
3. What is your role in the HIV Care Continuum?  
4.  Could you describe the work you are currently doing in the project?  
5. Do you have some work descriptions for your work, (your scope of practice)? (if yes, these are 
collected to the document analysis)  
6. How do you document the work you are doing? (all documentation mentioned is collected to 
the document analysis) 
7. Have there been any other changes in the HIV Care Continuum model since you started work 
in the HIV treatment cascade?  
8. (If there were changes) Why were these changes made? Did these changes affect how you 
conduct your daily routine? if yes, how? 
 
Participant responsiveness 
9. What are your perceptions about the HIV Care Continuum protocols? 
10. Do you feel sufficiently informed about what you are expected to do? 
11. Do you feel sufficiently supported to carry out work in this Care Continuum? 
Facilitation strategies 
12. Could you describe any factors that hinder or facilitate your work in the care continuum ?  
13. What conditions do you see as critical to the care continuum’s success? 
14. Do you have any concerns regarding the implementation of this care continuum? If yes, what 
are they? 
Complexities of an intervention 
15. What are the main issues that this care continuum can focus on to achieve adherence? 
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16. What activities in the care continuum lead to the desired effects? Name specific activities which 
you are/ should be practising in your facility. 
17. What do you think are the main benefits of this care continuum?  
18. Is there anything else that you would like to elaborate on or share regarding the HIV Care 
Continuum? 
 
-------------------------------------------------THE END------------------------------------------------------------- 
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Appendix 3: Wits Ethics Certificate 
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Appendix 4: Mpumalanga Ethics Certificate 
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Appendix 5: Agincourt Permission Letter  
 
4 November 2016 
Wits Human Research Ethics Committee (Medical) 
 
To Whom It May Concern 
 
Re: Permission for research study 
Lorraine Molepo is a student in the MSc Implementation Science programme, School of Public 
Health. Her research report is titled: “Implementation Fidelity of HIV Care Continuum among 
Healthcare Workers in Agincourt Healthcare Facilities”. 
Her proposed work complements the Tsima study currently underway – an NIH-funded cluster 
randomised trial of a community mobilisation intervention to increase testing, linkage to care and 
adherence to treatment.  
We have granted Lorraine permission to conduct data collection for her research in the MRC/Wits 
Rural Public Health and Health Transitions Research Unit (Agincourt), Bushbuckridge, Mpumalanga. 
 
Please don’t hesitate to contact me for further information. 
 
Yours  
 
Kathleen Kahn 
Professor, School of Public Health                                                                                                                                                          
Senior Scientist, MRC/Wits Rural Public Health and Health Transitions Research Unit (Agincourt) 
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Appendix 6: Information Sheet  
 
A study about Implementation Fidelity of HIV Care Continuum among 
Healthcare Workers in Agincourt Healthcare Facilities 
 
Greeting. 
I/we [name(s) of persons conducting the research]……………………………………………….  
are doing a research on processes involved in caring for HIV patients in your facility. The study aims 
to evaluate your experiences with the existing protocols for caring for HIV patients.  
The research will involve looking at patient records and clinic registers at your facility as well as 
interviewing you. A healthcare worker from each department involved in caring for HIV patients are 
recruited to take part in this interview. This is a once-off interview which will take approximately 30 
minutes of your time.  
This information will be conducted in the form of a recorded interview where you will be asked a series 
of questions to answer to the best of your ability. The recording is to ensure that all that is discussed 
during the session is captured. The tape would be kept strictly confidential and would be destroyed 
immediately after transcription. This study is purely for scientific purposes. Your name and identity 
will not be publicised in the result analysis and discussion. 
Participation in this study is voluntary, and you may stop with the interview if you do not feel 
comfortable answering any of the questions. 
This study will help us understand your everyday experiences which hinder or facilitate your work in 
caring for HIV positive patients. 
 In order to participate, it is requested of you to sign on the consent form overleaf. 
 
If you have any questions or concerns about the research, please feel free to contact:  
Lorraine Molepo or my supervisor(s): msbotse2@gmail.com ; Kathleen.kahn@students.wits.ac.za; 
ajuliens@email.unc.edu 
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Appendix 7: Informed Consent Form 
 
A study about Implementation Fidelity of HIV Care Continuum among 
Healthcare Workers in Agincourt Healthcare Facilities 
--------------------------------------------------------------------------------------------------------------------------- 
Participant declaration: 
I hereby confirm that I have been informed by the study staff (________________) about the nature, 
conduct, benefits and risks of the study. 
I have also received, read and understood the above written information (Participant Information 
Leaflet and Informed Consent) regarding the study. 
I am aware that the results of the study, including any personal details such as those regarding my 
name or job title will be anonymously processed into a study report. 
In view of the requirements of research, I agree that the data collected during this study can be 
processed in a computerised system by Wits study staff or on their behalf.  
I may, at any stage, without prejudice, withdraw my consent and participation in the study. 
I have had sufficient opportunity to ask questions and (of my own free will) declare myself prepared 
to participate in the study. 
___________________   __________________  _________ 
Signature of participant   Place     Date 
 
Statement by the researcher: 
I have provided written information regarding the study project. I agree to answer any further 
questions regarding the research study project. I shall adhere to the approved protocol. 
__________________   __________________  _________ 
Name of researcher   Signature   Date 
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Appendix 8: Recording Consent Form 
 
A study about Implementation Fidelity of HIV Care Continuum among 
Healthcare Workers in Agincourt healthcare facilities 
--------------------------------------------------------------------------------------------------------------------------- 
Participant declaration  
In addition to the informed consent signed, I hereby confirm that I have been informed by the study 
staff (__________________) that this interview will be recorded, and I consent for the tape recorder 
to be used during my interview.  
  
___________________   __________________  _________ 
Signature of participant                          Place    Date 
 
Statement by the researcher 
I hereby declare that the information gathered using the recording device is for purposes of gathering 
information efficiently and will be used for transcribing purposes only. The recording device will be 
securely protected and information kept confidential. 
__________________   __________________  _________ 
Name of researcher    Signature  Date 
 
 
 
 
 
 
 
 
 
 
 
